Dermapharm floats to finance growth
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
German OTC and generics specialist Dermapharm is looking to raise around €100 million through an initial public offering (IPO) on the Frankfurt Stock Exchange during the first half of this year.